Patents by Inventor Gangamani S. Beligere

Gangamani S. Beligere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF AN ANTI-B-CORONAVIRUS ANTIBODY IN A SAMPLE
    Publication number: 20230258638
    Abstract: Disclosed herein are methods, kits, systems, algorithms and improvements for detecting the presence of or determining an amount, quantity, concentration and/or level of an antibody against at least one type of ?-coronavirus, such as, for example, an antibody against SARS-CoV or SARS-CoV-2, in one or more samples obtained from a subject. In some aspects, the methods, kits and systems relate to detecting the presence of or determining an amount, quantity, concentration and/or level of at least one type of anti-?-coronavirus antibody, such as an IgG and/or IgM antibody, in one or more samples obtained from a subject.
    Type: Application
    Filed: October 12, 2022
    Publication date: August 17, 2023
    Inventors: A. Scott Muerhoff, John C. Prostko, James L. Stewart, Mary A. RODGERS, Gavin A. CLOHERTY, James Hartnett, Jeff Moore, Kathy Otis, Alak Kar, Bailin Tu, Bryan Tieman, Carolyn Strobel, David Hawksworth, Robert Ziemann, Zhihong Lin, Chris Marohnic, Peter Wiebe, Todd Meyer, Weijie Jiao, Gangamani S. Beligere, Saminathan X. Muthusamy, Jessica L. Grieshaber, Sandra K. Pearce, Edwin C. Frias, Russell E. Taylor, Kelly Coller, Yangrong E. Zhang, Thomas T. Biegalski, David J. Daghfal, Claudio Galli, Sergey Y. Tetin, Qiaoqiao Ruan, Patrick MacDonald, Michael S. Cassidy, Mary E. Gardiner, Mary Ann P. Palafox, Matthew S. Matias, Melissa B. Brennan, Philip W. Schultz, Beth C. Trudeau
  • METHODS FOR MEASURING UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 LEVELS IN BLOOD
    Publication number: 20220128579
    Abstract: Disclosed herein are improved methods of processing, measuring, and detecting levels of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) in blood samples taken from a human subject at time points within about 8 hours (or about 8 hours or less) after obtaining the sample from the subject. UCH-L1 is an early biomarker for traumatic brain injury (TBI), and there is a need for improved methods for assessing UCH-L1 in blood can aid in the diagnosis and evaluation of a human subject who has sustained or may have sustained a head injury.
    Type: Application
    Filed: September 30, 2021
    Publication date: April 28, 2022
    Inventors: Gangamani S. Beligere, Melissa B. Brennan, Jessica Grieshaber, David Pacenti, Saul A. Datwyler, John M. Ramp
  • Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
    Patent number: 11169159
    Abstract: Disclosed herein are improved methods of processing, measuring, and detecting levels of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) in blood samples taken from a human subject at time points within about 8 hours (or about 8 hours or less) after obtaining the sample from the subject. UCH-L1 is an early biomarker for traumatic brain injury (TBI), and there is a need for improved methods for assessing UCH-L1 in blood can aid in the diagnosis and evaluation of a human subject who has sustained or may have sustained a head injury.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: November 9, 2021
    Assignee: Abbott Laboratories
    Inventors: Gangamani S. Beligere, Melissa B. Brennan, Jessica Grieshaber, David Pacenti, Saul A. Datwyler, John M. Ramp
  • METHODS FOR MEASURING UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 LEVELS IN BLOOD
    Publication number: 20190033327
    Abstract: Disclosed herein are improved methods of processing, measuring, and detecting levels of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) in blood samples taken from a human subject at time points within about 8 hours (or about 8 hours or less) after obtaining the sample from the subject. UCH-L1 is an early biomarker for traumatic brain injury (TBI), and there is a need for improved methods for assessing UCH-L1 in blood can aid in the diagnosis and evaluation of a human subject who has sustained or may have sustained a head injury.
    Type: Application
    Filed: July 2, 2018
    Publication date: January 31, 2019
    Inventors: Gangamani S. Beligere, Melissa B. Brennan, Jessica Grieshaber, David Pacenti, Saul A. Datwyler, John M. Ramp
  • Composition and method for the diagnosis and treatment of iron-related disorders
    Patent number: 9636398
    Abstract: Provided herein are antibodies and methods of using the antibodies to treat, prevent, modulate, attenuate and diagnose iron-related disorders.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: May 2, 2017
    Assignees: ABBVIE DEUTSCHLAND GMBH & CO. KG, ABBVIE INC.
    Inventors: Gangamani S. Beligere, Shamila Manoj, Elaine M. Brate, Frank C. Grenier, David J. Hawksworth, Robert N. Ziemann, Larry G. Birkenmeyer, Bernhard Mueller, Andreas Popp, Susan Brophy
  • Antibodies relating to PIVKA-II and uses thereof
    Patent number: 9120862
    Abstract: The present disclosure relates to antibodies and immunoassay methods for use in the diagnosis, treatment and prevention of hepatocellular carcinoma (HCC), liver cancer and related conditions.
    Type: Grant
    Filed: July 26, 2010
    Date of Patent: September 1, 2015
    Assignees: ABBOTT LABORATORIES, ABBOTT JAPAN
    Inventors: Toru Yoshimura, Barry Lee Dowell, Gangamani S. Beligere, Eisaku Yoshida
  • Antibodies relating to PIVKAII and uses thereof
    Patent number: 8283162
    Abstract: The present invention relates to antibodies that may be used, for example, in the diagnosis, treatment and prevention of haepatocellular carcinoma (HCC), liver cancer and related conditions.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: October 9, 2012
    Assignee: Abbott Laboratories
    Inventors: Toru Yoshimura, Barry L. Dowell, Gangamani S. Beligere, Qiaoqiao Ruan
  • ANTIBODIES RELATING TO PIVKA-II AND USES THEREOF
    Publication number: 20120020972
    Abstract: The present disclosure relates to antibodies and immunoassay methods for use in the diagnosis, treatment and prevention of hepatocellular carcinoma (HCC), liver cancer and related conditions.
    Type: Application
    Filed: July 26, 2010
    Publication date: January 26, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Toru Yoshimura, Barry Lee Dowell, Gangamani S. Beligere, Eisaku Yoshida
  • Compositions comprising human brain natriuretic peptide (BNP) fragments
    Patent number: 8013112
    Abstract: The present invention relates among other things to a composition comprising at least two (2) human BNP fragments, wherein each of the human BNP fragments of the composition are cross-linked to at least one of the other human BNP fragments of the composition.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: September 6, 2011
    Assignee: Abbott Laboratories
    Inventors: Huaiqin Wu, Gangamani S. Beligere, Reika L. Campbell
  • ANTIBODIES RELATING TO PIVKAII AND USES THEREOF
    Publication number: 20100233175
    Abstract: The present invention relates to antibodies that may be used, for example, in the diagnosis, treatment and prevention of haepatocellular carcinoma (HCC), liver cancer and related conditions.
    Type: Application
    Filed: March 10, 2009
    Publication date: September 16, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Toru Yoshimura, Barry L. Dowell, Gangamani S. Beligere, Qiaoqiao Ruan
  • BIOMARKER FRAGMENTS FOR THE DETECTION OF HUMAN BNP
    Publication number: 20080248491
    Abstract: The present invention relates among other things to a composition comprising at least two (2) human BNP fragments, wherein each of the human BNP fragments of the composition are cross-linked to at least one of the other human BNP fragments of the composition.
    Type: Application
    Filed: May 29, 2008
    Publication date: October 9, 2008
    Inventors: Huaiqin Wu, Gangamani S. Beligere, Reika L. Campbell
  • Biomarker fragments for the detection of human BNP
    Publication number: 20080064045
    Abstract: The present invention relates among other things to a composition comprising at least two (2) human BNP fragments, wherein each of the human BNP fragments of the composition are cross-linked to at least one of the other human BNP fragments of the composition.
    Type: Application
    Filed: September 7, 2006
    Publication date: March 13, 2008
    Inventors: Huaiqin Wu, Gangamani S. Beligere